Jinpeng Liu
- Ophthalmology top 10%
- Retinal Diseases and Treatments 5
- Glaucoma and retinal disorders 4
-
- Sphingolipid Metabolism and Signaling 3
- Protein Kinase Regulation and GTPase Signaling 2
- Ubiquitin and proteasome pathways 2
-
- Corneal surgery and disorders 10
-
- Ophthalmology and Visual Impairment Studies 6
-
- Atrial Fibrillation Management and Outcomes 2
- Co-authors
- Hideaki TomuraMayumi KomachiMasayuki ToboKōichi SatoFumikazu OkajimaChihiro MogiAlatangaole DamirinJu-Qiang Wang
- Journals
- Journal of Clinical Investigation (1 paper)SHILAP Revista de lepidopterología (1 paper)Journal of Applied Physics (1 paper)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Jinpeng Liu
34 papers receiving 368 citations
Peers
Comparison fields: 5 of 76
- Ophthalmology 38
- Molecular Biology 188
- Biochemistry 18
- Radiology, Nuclear Medicine and Imaging 54
- Cancer Research 34
Countries citing papers authored by Jinpeng Liu
This map shows the geographic impact of Jinpeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinpeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinpeng Liu more than expected).
Fields of papers citing papers by Jinpeng Liu
This network shows the impact of papers produced by Jinpeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinpeng Liu. The network helps show where Jinpeng Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jinpeng Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 10 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 10 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 6 | |
| 11 | 2024 | 4 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 0 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 3 | |
| 16 | 2023 | 11 | |
| 17 | 2023 | 12 | |
| 18 | 2022 | 5 | |
| 19 | 2010 | 20 | |
| 20 | 2007 | 45 |
About Jinpeng Liu
Jinpeng Liu is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 42 papers that have together received 371 indexed citations. Recurring topics across this work include Corneal surgery and disorders (10 papers), Ophthalmology and Visual Impairment Studies (6 papers), Retinal Diseases and Treatments (5 papers), Glaucoma and retinal disorders (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Ophthalmology (38 citations), Molecular Biology (188 citations) and Biochemistry (18 citations). Jinpeng Liu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Hideaki Tomura, Mayumi Komachi, Masayuki Tobo, Kōichi Sato, Fumikazu Okajima, Chihiro Mogi, Alatangaole Damirin, Ju-Qiang Wang, Dong‐Soon Im and Hiromi Nochi. Their work appears in journals such as Journal of Clinical Investigation, SHILAP Revista de lepidopterología and Journal of Applied Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.